Business Description
![ConvaTec Group PLC ConvaTec Group PLC logo](https://static.gurufocus.com/logos/0C00004X2B.png?14)
ConvaTec Group PLC
ISIN : US21244X1090
Share Class Description:
CNVVY: ADRDescription
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 33% and 29% of total revenue, respectively. Continence care has become a slightly smaller business (21% of revenue) following the decision to exit the acute care market, and infusion sets contribute 17% of consolidated revenue.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.07 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 0.85 | |||||
Debt-to-EBITDA | 2.87 | |||||
Interest Coverage | 3.74 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.4 | |||||
Beneish M-Score | -2.84 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.5 | |||||
3-Year EBITDA Growth Rate | 4.4 | |||||
3-Year EPS without NRI Growth Rate | 6 | |||||
3-Year FCF Growth Rate | -7.4 | |||||
3-Year Book Growth Rate | 1.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 12.64 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.71 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 28.57 | |||||
9-Day RSI | 37.89 | |||||
14-Day RSI | 41.78 | |||||
6-1 Month Momentum % | -4.01 | |||||
12-1 Month Momentum % | 2.7 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.26 | |||||
Quick Ratio | 1.27 | |||||
Cash Ratio | 0.25 | |||||
Days Inventory | 148.69 | |||||
Days Sales Outstanding | 56.37 | |||||
Days Payable | 100.4 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.1 | |||||
Dividend Payout Ratio | 0.46 | |||||
3-Year Dividend Growth Rate | 6.8 | |||||
Forward Dividend Yield % | 2.1 | |||||
5-Year Yield-on-Cost % | 2.25 | |||||
3-Year Average Share Buyback Ratio | -0.7 | |||||
Shareholder Yield % | 2.9 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 55.96 | |||||
Operating Margin % | 13.23 | |||||
Net Margin % | 6.96 | |||||
FCF Margin % | 11.7 | |||||
ROE % | 9.23 | |||||
ROA % | 4.14 | |||||
ROIC % | 6.9 | |||||
3-Year ROIIC % | 13.51 | |||||
ROC (Joel Greenblatt) % | 32.1 | |||||
ROCE % | 8.49 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 40.51 | |||||
Forward PE Ratio | 17.92 | |||||
PE Ratio without NRI | 22.37 | |||||
Shiller PE Ratio | 239.8 | |||||
Price-to-Owner-Earnings | 20.65 | |||||
PEG Ratio | 27.96 | |||||
PS Ratio | 2.72 | |||||
PB Ratio | 3.58 | |||||
Price-to-Free-Cash-Flow | 23.14 | |||||
Price-to-Operating-Cash-Flow | 15.81 | |||||
EV-to-EBIT | 28.19 | |||||
EV-to-Forward-EBIT | 20.23 | |||||
EV-to-EBITDA | 15.67 | |||||
EV-to-Forward-EBITDA | 11.54 | |||||
EV-to-Revenue | 3.5 | |||||
EV-to-Forward-Revenue | 3.13 | |||||
EV-to-FCF | 28.97 | |||||
Price-to-Projected-FCF | 1.63 | |||||
Earnings Yield (Greenblatt) % | 3.55 | |||||
FCF Yield % | 4.17 | |||||
Forward Rate of Return (Yacktman) % | 4.91 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CNVVY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ConvaTec Group PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 2,200.3 | ||
EPS (TTM) ($) | 0.296 | ||
Beta | 0.89 | ||
Volatility % | 31.87 | ||
14-Day RSI | 41.78 | ||
14-Day ATR ($) | 0.306129 | ||
20-Day SMA ($) | 12.282375 | ||
12-1 Month Momentum % | 2.7 | ||
52-Week Range ($) | 9.9 - 15.4 | ||
Shares Outstanding (Mil) | 511.45 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ConvaTec Group PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ConvaTec Group PLC Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
ConvaTec Group PLC Frequently Asked Questions
What is ConvaTec Group PLC(CNVVY)'s stock price today?
The current price of CNVVY is $11.99. The 52 week high of CNVVY is $15.40 and 52 week low is $9.90.
When is next earnings date of ConvaTec Group PLC(CNVVY)?
The next earnings date of ConvaTec Group PLC(CNVVY) is 2025-03-06 Est..
Does ConvaTec Group PLC(CNVVY) pay dividends? If so, how much?
The Dividend Yield %  of ConvaTec Group PLC(CNVVY) is 2.1% (As of Today), Highest Dividend Payout Ratio of ConvaTec Group PLC(CNVVY) was 0.49. The lowest was 0.08. And the median was 0.46. The  Forward Dividend Yield % of ConvaTec Group PLC(CNVVY) is 2.1%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |